×

Extended release tablet formulations of flibanserin and method for manufacturing the same

  • US 20080038347A1
  • Filed: 08/13/2007
  • Published: 02/14/2008
  • Est. Priority Date: 08/14/2006
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical release system comprising a therapeutically effective amount of flibanserin, or pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient, wherein the composition exhibits a pharmacokinetic profile that is characterized by an average maximum flibanserin plasma concentration Cmax of less than 300 ng/mL after administration of a single dose to healthy volunteers in fasted state or directly after a meal.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×